RNASET2 and Cowden disease: We have previously reported that downregulation in RNASET2 expression is a component of TL1A-mediated enhancement of IFN−γ secretion and in CD patients the RNASET2 disease risk variant is associated with decreased expression and increased IFN−γ expression (27).